Guidelines & Advice

Most Popular Documents

See which documents other people are reading and reviewing most often. The list is updated on a regular basis to give you the most current information.

Displaying Most Popular Documents

453 Items

The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer

Document Status: Archived
ID: CED 1

Jun 2005

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma

Document Status: Archived
ID: 8-3

Sep 2011

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Document Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020

Adjuvant Hormonal Therapy for Stage I Endometrial Cancer

Document Status: Archived
ID: 4-14

Oct 2007

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

Document Status: Archived
ID: 2-18

Jun 2011

Guidance on the Substitution of Systemic Therapy Agents

Document Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Bevacizumab for Recurrent Glioblastoma Multiforme (GBM)

Document Status: Archived
ID: CED 19

Jul 2010

The Role of Bevacizumab (Avastin®) Combined with Chemotherapy in the Treatment of Patients with Advanced Colorectal Cancer

Document Status: Archived
ID: 2-25

Dec 2013

The Prophylactic Use of Filgrastim in Patients with Hematological Malignancies

Document Status: Archived
ID: CED 14-1

Sep 2009

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Document Status: Current
ID: GL 1-23-A

Jul 2021

Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Lung Cancer

Document Status: Archived
ID: 7-19

Oct 2012

Gastroscopy Following a Positive Fecal Occult Blood Test (FOBT) and Negative Colonoscopy

Document Status: Archived
ID: 15-6

Mar 2009